MAT Expansion in Rural Oklahoma

Information

  • Research Project
  • 9560711
  • ApplicationId
    9560711
  • Core Project Number
    R18HS025067
  • Full Project Number
    5R18HS025067-03
  • Serial Number
    025067
  • FOA Number
    RFA-HS-16-001
  • Sub Project Id
  • Project Start Date
    9/30/2016 - 7 years ago
  • Project End Date
    9/29/2019 - 4 years ago
  • Program Officer Name
    NOURJAH, PARIVASH
  • Budget Start Date
    9/30/2018 - 5 years ago
  • Budget End Date
    9/29/2019 - 4 years ago
  • Fiscal Year
    2018
  • Support Year
    03
  • Suffix
  • Award Notice Date
    9/11/2018 - 6 years ago

MAT Expansion in Rural Oklahoma

Title: MAT Expansion in Rural Oklahoma PROJECT SUMMARY/ABSTRACT The State of Oklahoma is among the States hardest hit by a combination of uncontrolled national trends in nonmedical uses of opioid prescription drugs, past-year heroin use, and opioid-related mortality. A highly rural state, Oklahoma is challenged to identify and reach persons with unmet treatment needs despite ongoing State efforts to improve access to community-based substance abuse treatment services, promote awareness of the opioid epidemic, foster safe prescribing of opioid prescription drugs, and prevent diversion. In response to the Agency for Healthcare Research and Quality?s (AHRQ) funding opportunity to expand access to medication- assisted treatment (MAT) in rural primary care, this project will develop, implement, and test an intervention to support primary care providers in three regions of rural Oklahoma in their adoption of MAT as an evidence- based strategy for treating persons with opioid use disorder. Objectives of the study include: ? Improving access to appropriate care for persons with or at risk of opioid use disorder (OUD) in heavily rural sections of the state that face particular challenges with opioid-related morality and/ or unmet treatment need; ? Preparing primary care providers to identify and care for persons with OUD using evidence-based and comprehensive treatment that provides a combination of pharmacologic and psychosocial therapies; ? Understanding and addressing potential barriers to the uptake of MAT in office-based settings; and ? Disseminating effective and replicable strategies for overcoming barriers to MAT adoption to help other rural communities improve access to and quality of care for persons with OUD. To accomplish these objectives, participating providers will be supported in their initiation and use of MAT through comprehensive training, case-based learning opportunities, practice facilitation, and individualized consultation on special topics. The implementation will be evaluated using a mixed-methods pre-/post- implementation design to assess changes in process of care and access to care for persons with OUD, as well as changes in provider attitudes and beliefs to assess the effectiveness of the implementation supports in overcoming known barriers to achieving the full promise of MAT in office-based settings.

IC Name
AGENCY FOR HEALTHCARE RESEARCH AND QUALITY
  • Activity
    R18
  • Administering IC
    HS
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    226
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZHS1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AMERICAN INSTITUTES FOR RESEARCH
  • Organization Department
  • Organization DUNS
    041733197
  • Organization City
    WASHINGTON
  • Organization State
    DC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    200073835
  • Organization District
    UNITED STATES